漳州片仔癀药业控股股东九龙江集团增持股份，持股比例升至51.5%

要点汇总

• 控股股东九龙江集团于2026年2月11日至4月30日期间，通过上海证券交易所集中竞价方式增持片仔癀A股3,171,311股，累计增持金额为49,999.76万元人民币。
• 增持后，九龙江集团持股由50.97%提升至51.50%，巩固了对公司的控股地位。
• 本次增持金额已超过增持计划下限，且未触及法定2%增持上限，免于发出收购要约。
• 九龙江集团为国有企业，股权结构稳定，控股股东地位进一步加强。
• 片仔癀已依法履行了信息披露义务，后续将公告增持实施结果。

详细解读

根据北京市君致律师事务所出具的法律意见书，漳州片仔癀药业股份有限公司（简称“片仔癀”，A股代码：未披露）的控股股东——漳州市九龙江集团有限公司（以下简称“九龙江集团”）于2026年2月11日至2026年4月30日，通过上海证券交易所系统以集中竞价交易方式，累计增持片仔癀A股3,171,311股，占已发行总股本的0.53%，增持金额达49,999.76万元人民币。

增持前，九龙江集团持有片仔癀307,522,643股A股，占总股本的50.97%。此次增持后，持股总数升至310,693,954股，持股比例升至51.50%。本次增持计划是在2026年2月1日至7月31日期间，以自有及专项贷款资金，计划增持金额区间为3亿元至5亿元人民币。截止本报告出具日，增持金额已达到计划下限。

增持主体资质与合规性

• 九龙江集团为依法设立、有效存续的国有企业，控股股东为漳州市人民政府国有资产监督管理委员会（持股90%），福建省财政厅（持股10%）。
• 律师核查确认九龙江集团不存在《上市公司收购管理办法》第六条所列禁止收购情形，包括重大违法、失信或未清偿重大债务等情况。

信息披露及合规性

• 片仔癀已依法在上海证券交易所网站披露增持计划、专项贷款承诺函及权益变动提示性公告。
• 本次增持未超过总股本2%，符合《收购管理办法》第六十三条“免于发出要约”的规定。
• 增持后，片仔癀需继续履行信息披露义务，包括公告增持实施结果等。

投资者关注要点与潜在影响

• 九龙江集团进一步提升控股权，有助于公司治理稳定和战略连续性，或将对公司长期发展构成正面影响。
• 本次大额增持显示控股股东对公司未来发展的信心，可能提振市场对公司股票的认可。
• 由于增持比例未超过2%，无需触发强制收购要约，减小了公司股权结构波动的风险。
• 后续如有更多增持或重大事项披露，投资者需持续关注相关公告。

结论

九龙江集团此次大额增持片仔癀股份，进一步巩固控股地位，显示出国有控股方对企业发展的持续看好。信息披露合规，未触发要约收购义务。此举有利于公司治理结构的稳定与市场信心，或对公司股价产生积极影响。投资者应关注后续公告及相关信息披露。

免责声明：本文内容基于公开法律意见书及相关公告，仅供参考，不构成任何投资建议。投资有风险，决策需谨慎。

English Translation

Zhangzhou Pien Tze Huang’s Controlling Shareholder, Jiulongjiang Group, Increases Holdings to 51.5%

Key Highlights

• Controlling shareholder Jiulongjiang Group increased its holdings by 3,171,311 A-shares between Feb 11 and Apr 30, 2026, via centralized bidding on the Shanghai Stock Exchange, with a total increase of RMB 499.9976 million.
• After the increase, Jiulongjiang Group’s stake rose from 50.97% to 51.50%, further consolidating its controlling position.
• The increased amount exceeded the plan’s lower limit and did not exceed the 2% statutory threshold, thus exempting it from a takeover bid requirement.
• Jiulongjiang Group is a state-owned enterprise with a stable shareholding structure, and its controlling status has been further strengthened.
• Pien Tze Huang has fulfilled current information disclosure obligations, and will subsequently announce the implementation results of the share increase.

In-depth Explanation

According to the legal opinion issued by Beijing Junzhi Law Firm, Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (referred to as “Pien Tze Huang”)’s controlling shareholder, Zhangzhou Jiulongjiang Group Co., Ltd. (Jiulongjiang Group), accumulated an increase of 3,171,311 A-shares—representing 0.53% of total issued share capital—between February 11 and April 30, 2026, with an increase worth RMB 499.9976 million through centralized bidding on the Shanghai Stock Exchange.

Before the increase, Jiulongjiang Group held 307,522,643 A-shares (50.97%). After the increase, the holding rose to 310,693,954 shares (51.50%). The increase plan was set for February 1 to July 31, 2026, with a target range of RMB 300 million to 500 million. As of the report date, the lower threshold of the plan has been achieved.

Eligibility & Compliance

• Jiulongjiang Group is a lawfully established, validly existing state-owned enterprise, with 90% held by Zhangzhou State-owned Assets Supervision and Administration Commission and 10% by Fujian Provincial Department of Finance.
• Lawyers confirmed Jiulongjiang Group does not fall under the prohibited circumstances for share acquisition as set forth in Article 6 of the Takeover Regulations (e.g., significant illegality, default, or unsettled major debts).

Disclosure & Regulatory Compliance

• Pien Tze Huang has lawfully disclosed the share increase plan, special loan commitment, and equity change announcements on the Shanghai Stock Exchange website.
• The increase did not exceed 2% of total issued capital, complying with the “exemption from takeover bid” under Article 63 of the Takeover Regulations.
• Pien Tze Huang must continue to disclose the implementation results of this share increase.

Investor Focus & Potential Impact

• Further consolidation of the controlling shareholder’s stake may support corporate governance stability and strategic continuity, positively affecting long-term development.
• The substantial increase demonstrates the controlling shareholder’s confidence in the company’s future, which could boost market confidence in the shares.
• As the increase is below the 2% threshold, it avoids triggering a mandatory takeover bid and reduces risks of shareholding structure turbulence.
• Investors should monitor for further increases or material disclosures.

Conclusion

Jiulongjiang Group’s significant increase in Pien Tze Huang shares further consolidates control, demonstrating sustained confidence in the company’s prospects. The information disclosure is compliant, with no need for a takeover offer. This move is beneficial for governance stability and market confidence, and may positively impact the share price. Investors should stay tuned for further announcements and disclosures.

Disclaimer: This article is based on public legal opinions and disclosures, and is for reference only. It does not constitute any investment advice. Investments carry risk; please make decisions prudently.

View 片仔癀 Historical chart here